NCT02222350View on ClinicalTrials.gov

Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

10mg DS-8500a tablet

DRUG

75mg DS-8500a tablet

DRUG

placebo

Trial Locations (1)

565-0853

Heishinkai Medical Group Incorporated OCROM Clinic, Kasuga

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT02222350 - Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter